The global epidermal growth factor receptor (EGFR) inhibitors market is projected to grow at a CAGR of 8.6% during the forecast period of 2020-2025. The growing incidences of cancer globally, along with the increasing geriatric population and lifestyle changes are some of the major drivers for the industry growth. Epidermal growth factor inhibitors (EGFRI) is the first targeted cancer therapy, which has become an essential treatment for many advance-stage epithelial cancers. In comparison to conventional chemotherapies, these agents have the superior ability to target cancer cells, further offering better safety profile to the patients.
Get a Free Sample Report with Table of Content - Download Now
Properties and Applications
Epidermal growth factor receptor (EGFR) inhibitors are medicines that slow down or stop EGFR’s activity, a protein found on the surface of some normal cells, by binding to its certain part. EGFR or epidermal growth factor receptor causes cells to divide upon binding to it by signalling pathways that control cell division and survival, leading to the growth of normal cells. Certain mutations in EGFR are known to be vulnerable and can lead to the growth of cancer cells.
The global epidermal growth factor receptor (EGFR) inhibitors industry can be divided based on segments like indication and region.
Based on indication, the industry can be segmented into:
The EMR report looks into the regional epidermal growth factor receptor (EGFR) markets like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.
The global epidermal growth factor receptor inhibitors industry is being supported by the increase in the number of cancer cases such as lung cancer, colorectal cancer, breast cancer, and others. The growing incidences of cancer throughout the world also calls for more efficient therapy techniques that encourage scientists to create EGFR antibodies. Because of the busy lifestyle, excessive alcohol consumption and smoking habits, the incidence of cancer is quickly growing, particularly in regions like North America and Europe. The increasing morbidity and mortality rates among patients with cancer are leading to enhanced demand for EGFR antibodies, thus driving the market forward. Due to an enormous unmet need for new therapies to treat cancer symptoms, several pharmaceutical companies are focusing on the development of advanced EGFR inhibitors to capitalise on this enormous unmet need, which is expected to aid the industry over the forecast period.
The report presents a detailed analysis of the following key players in the global epidermal growth factor receptor (EGFR) inhibitors market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Questions Answered in the Market Report:
1.1 Objectives of the Study
1.1.1 Research Objective
1.1.2 Key Findings of the Report
2 Research Methodology
2.1 Data Extraction
2.2 Data Corroboration
2.3 Market Structure
2.5 Market Models
3.1 Market Outlook
3.2 Market Scope and Segmentation
3.3 Additional Insights
4 Executive Summary
4.1 Key Market Developments
4.2 Market Analysis
4.3 Key Players
4.4 Cost Structure
4.5 Market Revenue and Growth
5 Market Dynamics
5.1 Market Driver Analysis
5.2 Market Restraint Analysis
5.3 Industry Challenges
5.4 Industry Opportunities
6 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Analysis
6.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market (2015-2019) & Forecast (2020-2025)
6.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Breakup by Indication
6.2.1 Lung cancer
6.2.2 Colorectal cancer
6.2.3 Breast cancer
6.3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Breakup by Indication: Historical Market (2015-2019) & Forecast (2020-2025)
6.3.1 Lung cancer
6.3.2 Colorectal cancer
6.3.3 Breast cancer
6.4 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Breakup by Region
6.4.1 North America
220.127.116.11 United States of America
18.104.22.168 United Kingdom
6.4.3 Asia Pacific
6.4.4 Latin America
6.4.5 Middle East & Africa
22.214.171.124 Saudi Arabia
126.96.36.199 United Arab Emirates
188.8.131.52 South Africa
6.5 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Breakup by Region: Historical Market (2015-2019) & Forecast (2020-2025)
6.5.1 North America
184.108.40.206 United States of America
220.127.116.11 United Kingdom
6.5.3 Asia Pacific
6.5.4 Latin America
6.5.5 Middle East & Africa
18.104.22.168 Saudi Arabia
22.214.171.124 United Arab Emirates
126.96.36.199 South Africa
7 SWOT Analysis
8 Porter’s Five Forces Analysis
8.2 Buyer’s Power
8.3 Supplier’s Power
8.4 New Entrants
8.5 Degree of Rivalry
9 Regional Price Analysis
9.1 North America Historical Price Trends (2015-2019) & Forecast (2020-2025)
9.2 Europe Historical Price Trends (2015-2019) & Forecast (2020-2025)
9.3 Asia Pacific Historical Price Trends (2015-2019) & Forecast (2020-2025)
9.4 Latin America Historical Price Trends (2015-2019) & Forecast (2020-2025)
9.5 Middle East & Africa Historical Price Trends (2015-2019) & Forecast (2020-2025)
10 Competitive Landscape & Supplier Analysis
10.1 Amgen Inc. (NASDAQ: AMGN)
10.1.1 Company Overview
10.1.2 Financial Analysis
10.2 AstraZeneca (LON: AZN)
10.2.1 Company Overview
10.2.2 Financial Analysis
10.3 Eli Lilly and Company (NYSE: LLY)
10.3.1 Company Overview
10.3.2 Financial Analysis
10.4 F. Hoffmann-La Roche Ltd. (SWX: ROG)
10.4.1 Company Overview
10.4.2 Financial Analysis
10.5 Novartis AG (SWX: NOVN)
10.5.1 Company Overview
10.5.2 Financial Analysis
11 Events and Developments
Additional Customization Available:
12 Feedstock Analysis
13 Procurement Strategy
13.1 Value Chain Analysis
13.2 Contract Terms
13.3 Buying and Sourcing Trends
13.4 Storage and Warehousing
13.5 Certifications and Regulations
13.6 Risk Factors
14 Trade Data Analysis
14.1 Major Exporting Countries: By Value and Volume
14.2 Major Importing Countries: By Value and Volume
15 Manufacturing Process
15.1 Detailed Process Flow
15.2 Operations Involved
15.3 Mass Balance
16 Cost Analysis and Project Economics
16.1 Land, Location and Site Development
16.3 Plant Machinery
16.4 Cost of Raw Material
16.9 Other Capital Investment
17 Production Cost Analysis
EMR is one of the foremost business intelligence and market research companies with a database of syndicated and customised reports spanning more than 100 industries across global and regional markets. We leverage the knowledge of our highly skilled team of over 100 analysts and more than 3000 independent consultants to provide our clients with thoroughly researched and reliable data tailored to their requirements. We help our clients, who range from Fortune 1000 companies to medium and niche enterprises, make informed strategic decisions through our varied tools and methodology.
Our meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. We understand the distinct nature and requirements for each industry and thus, modify our methodology to best fit the industry in question. Our research methodology uses a combination of cutting-edge analytical tools and the expertise of our highly accomplished team, thus, providing our customers with industry insights that are accurate, actionable, and help them remain ahead of their competition. EMR’ s fine-tuned research methodology and data analysis, formulated through years of cross-industry experience of our team, ensure that our clients are provided with:
Our approach gives our clients a comprehensive assessment of the prevailing and projected industry conditions through the collection, collation, and analysis of data from trusted sources.
We assess the historical, prevailing, and expected prices of commodities and raw materials by analysing our assiduously collected data from verified primary and secondary sources. Our assessments reflect the market values of related commodities within a region to help our consumers understand the interdependencies and formulate profitable industry strategies. Our price assessments cover both the average global prices along with the prevailing regional prices.
Our market assessments determine the global and regional production and consumption of the product, according to their value and volume. We identify the key growth drivers, opportunities, and restraints that might promote or hinder the future industry growth along with an expansive overview of the competitive landscape to help our clients make informed strategic decisions. We also take into account the demographic, economic, cultural, and political factors that might influence the market.
We gather market intelligence through our extensive database of reliable secondary sources and our exhaustive interviews with multiple industry stakeholders. The information gathered through our primary and secondary sources help us verify and extrapolate data relating to prices, trade, and market fluctuations along with the latest developments in the industry.
As a part of our primary research, we interact with highly placed industrial professionals possessing an expansive and meticulous insight into the market. We conduct our interviews via mails, telephonic conversations, and one-on-one meetings. Thus, our exhaustive interviews with both buyers and consumers help us provide our clients with verified intelligence regarding the market size, share, drivers, prices, and forecast along with a detailed assessment of your supply chain.
EMR has access to extensive internal and subscribed databases, which apprise us of the historical and prevailing industry conditions and help us forecast the market for the coming few years. Our secondary research involves a wide array of sources ranging from the annual and financial reports of the key players in the industry to governmental and regulatory databases. We refer to various scientific and industry publications and whitepapers to form a comprehensive understanding of the product and the supply chain. Our wide-ranging research also refers to relevant articles and press releases to provide our customers with an up-to-date understanding of the contemporary market. We derive extensive raw data from our secondary research, which then go through a thorough verification and validation process, to help us formulate an exhaustive understanding of the industry, the supply chain, the competitive landscape, and the product.
Other Analyst Tools and Data Models
Our extensive and intricate data models, formulated through our propriety technological and analytical resources, help you easily comprehend the expansive market data and aid you in framing vital business and industry strategies. Our tools provide you with a cohesive understanding of the industry outlook, taking into account the qualitative and quantitative market variables. Our analytical tools and models are regularly updated according to the changes in the continually evolving market scenarios as well as being adapted to best meet our client’s specific needs. Our research methods involve a blend of the best technological tools used in the industry along with the expertise of our analysts and consultants who can spot and assess the implications of the subtle factors influencing the more complex markets.
Our market assessments take into consideration only those data that are confirmed and are derived from credible and transparent sources. Thus, our clients are presented with accurate and infallible data which can be incorporated into their business strategies.
Before our data is presented to the clients, they undergo an intensive cross-verification and validation process. We corroborate the data gathered through our primary and secondary research by the review and validation of the initial sources along with the verification of the data from other thoroughly vetted sources.
Our qualitative and quantitative assessments are time-sensitive, reflecting the most recent value and volume of the market across regions. By constantly updating our databases and reports to reflect the changes taking place in the industry, our market and price assessments accurately reflect the prevailing industry conditions.
Thus, our rigorous data collection, thorough statistical analysis, and specialist assessments ensure that our clientele has a greater understanding of the industry space, supply chain, price fluctuations, competitive landscape, and other vital factors, helping them emerge as the undisputed industry leaders in their respective fields.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
The global cancer/tumour profiling market attained a value of USD around 7.8 billion in 2019. The cancer/tumour profiling market is further expected to grow in the forecast period of 2020-2025 at a CA...
The global wellness genomics market attained a value of USD 4 billion in 2019. The wellness genomics market is further expected to grow in the forecast period of 2020-2025 at a CAGR of 14% to reach US...
The global spatial genomics and transcriptomics market attained a value of USD 164 million in 2019. The industry is further expected to grow in the forecast period of 2020-2025 at a CAGR of 8.2% to re...
The global soft tissue allografts market attained a value of USD 3.92 billion in 2019. The soft tissue allografts market is further expected to grow in the forecast period of 2020-2025 at a CAGR of 7%...
North America is projected to be the largest regional market for label-free array systems driven by the rising demand for the product. The market in North America is being driven by the growing drug d...
Buy Full Version
"Epidermal Growth Factor Receptor (EGFR) Inhibitors Market" Purchase Enquiry